KRNY vs VRTX · P/E 14, rev $324.3M vs P/E 30, rev $3.33B
Kearny Financial Corp (KRNY) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Kearny Financial Corp (KRNY) is a banks - regional company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported KRNY revenue for 2026-06-30 was $324.3M. Net income was $36.3M. Revenue was down 0.1% from 2025-06-30 to 2026-06-30. KRNY currently screens at market cap $502.2M and trailing P/E 14.0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
KRNY currently screens at market cap $502.2M and trailing P/E 14.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the KRNY and VRTX stock pages for the full models.
Not investment advice.